Catheter-Related Bloodstream Infection (CRBSI) is defined as the presence of bacteremia occurring from an intravascular (I.V.) catheters.&nbsp;
CRBSI refers to bloodstream infection attributed to an intravascular catheter by quantitative culture of the catheter tip or by differences in growth between catheter and peripheral venipuncture blood culture specimens. Also known as catheter-related sepsis, it is the most common cause of nosocomial bacteremia.&nbsp;
&nbsp;
CRBSI occurs due to organisms like coagulase-negative staphylococcus, Staphylococcus aureus, enteric gram-negative bacilli, enterococci, and streptococci, pseudomonas, and others. CRBSI arises from bacterial seeding from biofilms that form on either the inside or outside of indwelling catheters.&nbsp;
&nbsp;
Risk factors associated with the development of catheter-associated infections can be divided into host-related problems and device-related issues.
&nbsp;
Catheter-Related Bloodstream Infections Epidemiological Segmentation&nbsp;
The Epidemiological Segmentation of Catheter-Related Bloodstream Infections in 7MM from 2017 to 2030 is segmented as:-&nbsp;
<ul>
<li>Total Incident Population of CRBSI</li>
<li>Total Diagnosed Incident Population of CRBSI</li>
<li>Diagnosed Incidence of CRBSI by Causative Pathogens&nbsp;</li>
</ul>
&nbsp;
Catheter-Related Bloodstream Infections Epidemiology&nbsp;
<ul>
<li>The incident population of CRBSI in the 7MM in 2017 was 669,393</li>
<li>The diagnosed incident cases in the 7MM in 2017 were 635,924</li>
</ul>
&nbsp;
<a style="color: #0066cc; background-color: transparent;" href="https://www.delveinsight.com/report-store/catheter-related-bloodstream-infection-market" target="_blank" rel="noopener noreferrer">Catheter-Related Bloodstream Infections Market</a>
Market Size of CRBSI in the 7MM in 2017 was USD 694.7 Million.&nbsp;
&nbsp;
Catheter-Related Bloodstream Infections Market Drivers
<ul>
<li>Competitive Landscape</li>
<li>Increasing Research and Development Activities</li>
<li>Cost-effectiveness of emerging Therapies</li>
</ul>
&nbsp;
Catheter-Related Bloodstream Infections Market Barriers
<ul>
<li>Poor Emerging Treatment Landscape</li>
<li>Lack of Epidemiological Data&nbsp;</li>
<li>Treatment failure or an extended treatment duration&nbsp;</li>
<li>Financial Funding</li>
</ul>
&nbsp;
Catheter-Related Bloodstream Infections Emerging Drugs
The emerging drugs of the Catheter-Related Bloodstream Infections market are&nbsp;
<ul>
<li>Mino-Lok</li>
</ul>
And many others.&nbsp;&nbsp;
&nbsp;
Catheter-Related Bloodstream Infections Marketed Therapies
The Marketed Therapies of the Catheter-Related Bloodstream Infections market are
<ul>
<li>Neutrolin</li>
<li>Taurosept</li>
<li>Taurolock</li>
<li>IntraLock</li>
</ul>
And many others.&nbsp;&nbsp;
&nbsp;
Catheter-Related Bloodstream Infections Key Players
The key players in the Catheter-Related Bloodstream Infections market are
<ul>
<li>Citius Pharmaceuticals</li>
<li>CorMedix</li>
<li>Geistlich Pharma</li>
<li>TauroPharm GmbH</li>
<li>Fresenius Medical Care</li>
</ul>
And many others.&nbsp;

Catheter-Related Bloodstream Infections Market

Catheter-Related Bloodstream Infections Symptoms, Treatment, epidemiology, companies, drugs infographic is a short guide to understand the problem and market landscape.